Skip to content
Putting Americans First: International prices in context
It is often taken as a given that drug prices in the U.S. ...
Read More
BIO’s Texas visit will highlight a growing biotech ecosystem
Already providing employment for 129,245 people and $95 billion in annual economic output, ...
Read More
Putting Americans First: No medicine is more expensive than the one patients can’t access
The most notable differences between the pharmaceutical market in the U.S. and those ...
Read More
BIO Coffee Chat looks at patient access after three years of the IRA
It has been three years since the Inflation Reduction Act (IRA) was signed ...
Read More
Riboway Therapeutics: Resilience, RNA, and redefining the undruggable
At this year’s BIO International Convention in Boston, Riboway Therapeutics emerged as the winner ...
Read More
Startup Stadium: Tezcat Biosciences targets common cancer mutation
A Rat sarcoma (RAS) mutation is an oncogene, a gene that causes cancer ...
Read More
EDITORS' CHOICE
A conversation with Fritz Bittenbender, new BIO Board Chair
The exciting new developments we’re seeing in biotechnology must be supported by equally innovative policy, according to Fritz Bittenbender, the new Chair of the Board ...
Read More
LATEST NEWS
BIO's View
Putting Americans First: International prices in context
It is often taken as a given that drug prices in the U.S. are higher than those in other nations. And while there is a ...
Health
BIO’s Texas visit will highlight a growing biotech ecosystem
Already providing employment for 129,245 people and $95 billion in annual economic output, Texas’s biotech sector is growing rapidly. That sector will be highlighted Sept. ...
BIO's View
Putting Americans First: No medicine is more expensive than the one patients can’t access
The most notable differences between the pharmaceutical market in the U.S. and those in other countries are not in the prices. They’re in the ability ...
Federal Policy
BIO Coffee Chat looks at patient access after three years of the IRA
It has been three years since the Inflation Reduction Act (IRA) was signed into law. “We have definitively seen negative impacts on patient access, and ...
BIO Events
Riboway Therapeutics: Resilience, RNA, and redefining the undruggable
At this year’s BIO International Convention in Boston, Riboway Therapeutics emerged as the winner of the 2025 BIO Start-Up Stadium seed-stage category. For founder and CEO ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
Federal Policy
State Policy
BIO’s Texas visit will highlight a growing biotech ecosystem
Already providing employment for 129,245 people and $95 billion in annual economic output, Texas’s biotech sector is growing rapidly. That ...
Read More
International
Bio's View
Putting Americans First: International prices in context
It is often taken as a given that drug prices in the U.S. are higher than those in other nations. ...
Read More
